SUBSCRIBE
SUBSCRIBE
News   Business

Dutch Crucell N.V. Posts Q2 Net Loss, Shares Drop

August 11, 2009 | 
1 min read
Bookmark and Share

Reuters -- Dutch biotech firm Crucell NV missed estimates on Tuesday as it reported a second-quarter net loss due to delayed vaccine shipments, sending its shares to a two-month low.
Earnings
MORE ON THIS TOPIC
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Ultragenyx Downsizes By 10% After Bone Drug’s Phase 3 Fail
February 13, 2026
 · 
54 min read
 · 
BioSpace Editorial Staff
Contemporary artwork. Businessman jumping over bear trap with briefcase and documents. Concept of business risk, hidden financial dangers, legal pitfalls, investment fraud and consumer protection.
Vaccines
Flu Vaccine Rejection Imperils Moderna’s Breakeven Plans
February 12, 2026
 · 
4 min read
 · 
Dan Samorodnitsky
Paul Hudson
People
Sanofi Shares Decline as Paul Hudson Removed as CEO, Making Way For Merck KGaA’s Belén Garijo
February 12, 2026
 · 
2 min read
 · 
Annalee Armstrong
Insights
Digital Pathology, AI and the Future of ADCs and HER2 Cancer Treatment
February 12, 2026
 · 
1 min read
 · 
Jennifer Smith-Parker